Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
葡萄糖素受体
拮抗剂化合物已被披露。这些化合物可用于治疗2型糖尿病及相关疾病。同时还包括药物组合物和治疗方法。